This report contains market size and forecasts of Hepatitis B Immune Globulin in global, including the following market information:
Global Hepatitis B Immune Globulin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hepatitis B Immune Globulin Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Hepatitis B Immune Globulin companies in 2021 (%)
The global Hepatitis B Immune Globulin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Intravenous Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatitis B Immune Globulin include ADMA Biologics, Bio Products Laboratory, Grifols, Biotest AG, CSL Behring, FFF Enterprises and Cleveland Clinic, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatitis B Immune Globulin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis B Immune Globulin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hepatitis B Immune Globulin Market Segment Percentages, by Type, 2021 (%)
Intravenous Injection
Intramuscular Injection
Global Hepatitis B Immune Globulin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hepatitis B Immune Globulin Market Segment Percentages, by Application, 2021 (%)
Liver Transplant Patients
Newborn Baby
Others
Global Hepatitis B Immune Globulin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hepatitis B Immune Globulin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis B Immune Globulin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hepatitis B Immune Globulin revenues share in global market, 2021 (%)
Key companies Hepatitis B Immune Globulin sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Hepatitis B Immune Globulin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
ADMA Biologics
Bio Products Laboratory
Grifols
Biotest AG
CSL Behring
FFF Enterprises
Cleveland Clinic